Nektar Therapeutics
NKTR
NKTR
123 hedge funds and large institutions have $106M invested in Nektar Therapeutics in 2024 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 50 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
123
Holders Change
-1
Holders Change %
-0.81%
% of All Funds
1.78%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
17
Increased
20
Reduced
50
Closed
17
Calls
$449K
Puts
$8K
Net Calls
+$441K
Net Calls Change
+$438K
Top Buyers
| 1 |
TCM
TCG Crossover Management
Palo Alto,
California
|
+$3.74M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.25M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$2.31M |
| 4 |
SC
Shay Capital
New York
|
+$1.94M |
| 5 |
Millennium Management
New York
|
+$1.3M |
Top Sellers
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$3.05M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.29M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$2.27M |
| 4 |
D.E. Shaw & Co
New York
|
-$1.45M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.39M |
